# FDA 483 - Lucina Egg Bank - April 10, 2026

Source: https://www.keypedia.com/records/483/lucina-egg-bank/d5ef4691-219f-466d-af54-1c4e7dc94f26

> FDA 483 for Lucina Egg Bank on April 10, 2026. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Lucina Egg Bank
- Inspection Date: 2026-04-10
- Product Type: biologics
- Office Name: Los Angeles District Office
- Summary: An FDA inspection of Lucina Egg Bank in San Diego, CA, a human reproductive tissue establishment, identified two observations. The firm's summary of records for HCT/Ps lacked statements regarding communicable disease testing laboratory certification and the address of the donor-eligibility determination establishment. These issues indicate deficiencies in record-keeping practices for human cells, tissues, and cellular and tissue-based products.

## Related Officers

- [Melsomar R. Ramos](https://www.keypedia.com/people/melsomar-r-ramos/395e7ddc-ed98-455a-a143-0ee5f46804f4)

Company: https://www.keypedia.com/companies/lucina-egg-bank/f41d27cb-8809-4fa6-8245-a765ca23173d

Office: https://www.keypedia.com/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b